000			01779 a2200265 4500
003			OSt
005			20240625123042.0
008			190716b xxu||||| |||| 00| 0 eng d
020			_a9781788014069
040			_cIIT Kanpur
041			_aeng
082			_a615.23 _bM564
245			_aMetal-based anticancer agents _cedited by Angela Casini, Anne Vessières and Samuel M. Meier-Menches.
260			_bRoyal Society of Chemistry _c2019 _aLondon
300			_axiii, 355p
440			_aMetallobiology series
490			_a/ edited by C. David Garner
520			_aMetal-based anticancer drugs are among the most successful therapeutic agents, as evidenced by the frequent prescription of selected platinum and arsenic compounds to patients. Metal-based Anticancer Agents covers the interdisciplinary world of inorganic drug discovery and development by introducing the most prominent compound classes based on different transition metals, discussing emerging concepts and enabling methods, as well as presenting key pre-clinical and clinical aspects. Recent progress on the unique features of next-generation targeted metal-based anticancer agents, including supramolecular coordination complexes used for both therapy and drug delivery, promise a bright future beyond the benefits of pure cytotoxic activity. With contributions from global leaders in the field, this book will serve as a useful reference to established researchers as well as a practical guide to those new to metallodrugs, and postgraduate students of medicinal chemistry and metallobiology.
650			_aMetals -- Therapeutic use
650			_aAntineoplastic agents
700			_aCasini, Angela [ed.]
700			_aVessières, Anne [ed.]
700			_aMeier-Menches, Samuel M. [ed.]
942			_cBK
999			_c560494 _d560494